Research and Training Funding

Funding Opportunity Announcements

Browse below for Data Science Funding Opportunity Announcements.

This page last reviewed on June 30, 2021

Feed last updated: July 08 2021 8:24 am
Title FOA/Notice Number Issuing Organization Release Date Expiration Date Activity Code
BRAIN Initiative: Tools for Germline Gene Editing in Marmosets (U01 - Clinical Trial Not Allowed) RFA-DA-21-006 NIDA Jul 17 2020 Oct 15 2022 U01
Broad Agency Announcement: Immune Mechanisms of Protection Against Mycobacterium tuberculosis Center (IMPAc-TB) NIAID-DAIT-NIHAI201700104 NOT-AI-18-019 NIAID Feb 16 2018 N/A N/A
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) PAR-21-035 NCI Nov 10 2020 Jan 08 2024 R01
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) PAR-21-066 NCI Nov 17 2020 Jan 08 2024 R25
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) PAR-21-067 NCI Nov 17 2020 Jan 08 2024 R25
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) PAR-18-711 NINDS Mar 15 2018 Jul 13 2021 K22
Career Transition Award for NINDS Intramural Clinician-Scientists (K22) - Clinical Trial Required PAR-18-710 NINDS Mar 15 2018 Jul 13 2021 K22
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) PAR-20-140 NIDDK Mar 16 2020 May 08 2023 R21
Center of Excellence for Research on Complementary and Integrative Health (P01,Clinical Trial Optional) PAR-20-138 NCCIH Mar 16 2020 May 08 2023 P01
Centers for AIDS Research (P30 Clinical Trial Not Allowed) PAR-20-106 NIAID Feb 03 2020 Jul 29 2022 P30
Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional) PAR-19-313 NIGMS Jul 10 2019 Jan 28 2022 P20
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) PAR-19-325 NCI Jul 30 2019 Feb 12 2022 R01
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) PAR-19-329 NHLBI Aug 05 2019 Sep 09 2022 UG3/UH3
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) PAR-21-243 NCCIH Jun 14 2021 Mar 12 2024 UG3/UH3
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required) PAR-20-215 NCCIH May 20 2020 May 08 2023 UG3/UH3
Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional) PAR-19-297 NIMH Jun 10 2019 Sep 08 2022 R01
Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01 Clinical Trial Optional) PAR-20-295 NCI Aug 28 2020 Oct 14 2021 R01
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed) PAR-18-952 NCATS Oct 04 2018 Oct 26 2021 R03
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) PAR-18-953 NCATS Oct 04 2018 Oct 26 2021 R21
Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed) PAR-19-220 NINDS Mar 13 2019 Feb 17 2022 U01
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) PAR-21-058 NINDS Nov 19 2020 Sep 08 2023 U01
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) PAR-21-059 NINDS Nov 19 2020 Sep 08 2023 U44
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Developmental Project (UH2 Clinical Trial Optional) RFA-AA-21-014 NIAAA Jun 02 2021 Aug 17 2021 UH2
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Project (U01 Clinical Trial optional) RFA-AA-21-010 NIAAA Jun 02 2021 Aug 17 2021 U01
Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed) PAR-19-171 NINDS Jan 28 2019 Jan 08 2022 UG3/UH3

Pages

XLS